These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24475141)

  • 1. Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner.
    Bae EH; Choi HS; Joo SY; Kim IJ; Kim CS; Choi JS; Ma SK; Lee J; Kim SW
    PLoS One; 2014; 9(1):e86553. PubMed ID: 24475141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.
    Fiorucci S; Antonelli E; Rizzo G; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pellicciari R; Morelli A
    Gastroenterology; 2004 Nov; 127(5):1497-512. PubMed ID: 15521018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
    Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
    Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
    Xu Y; Li D; Wu J; Zhang M; Shao X; Xu L; Tang L; Zhu M; Ni Z; Zhang M; Mou S
    Cell Prolif; 2021 Apr; 54(4):e13005. PubMed ID: 33594777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
    Li G; Kong B; Zhu Y; Zhan L; Williams JA; Tawfik O; Kassel KM; Luyendyk JP; Wang L; Guo GL
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):299-305. PubMed ID: 23811326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation.
    Xu S; Jia P; Fang Y; Jin J; Sun Z; Zhou W; Li J; Zhang Y; Wang X; Ren T; Zou Z; Ding X
    Kidney Int; 2022 May; 101(5):987-1002. PubMed ID: 35227690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Farnesoid X Receptor (FXR) Suppresses Linoleic Acid-Induced Inflammation in the Large Yellow Croaker (Larimichthys crocea).
    Du J; Chen Q; Li Y; Xiang X; Xu W; Mai K; Ai Q
    J Nutr; 2020 Sep; 150(9):2469-2477. PubMed ID: 32614453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of farnesoid X receptor gene aggravates cisplatin-induced kidney injury.
    Zhang L; Li A; Huang Z; Wang Y; Yi B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):174-182. PubMed ID: 35545407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
    Zhu JB; Xu S; Li J; Song J; Luo B; Song YP; Zhang ZH; Chen YH; Xie DD; Yu DX; Xu DX
    Eur J Pharmacol; 2018 Nov; 838():60-68. PubMed ID: 30196109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
    Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
    Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.
    Kim DH; Choi HI; Park JS; Kim CS; Bae EH; Ma SK; Kim SW
    Redox Biol; 2022 Aug; 54():102382. PubMed ID: 35767918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
    FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia-Reperfusion Injury.
    Wang X; Li S; Chen M; Liu J; Dong R; Wang H; Zhu S
    Shock; 2018 Sep; 50(3):316-323. PubMed ID: 29028769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
    Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
    Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.